Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126202032 | 12620203 | 2 | F | 20160724 | 20160922 | 20160803 | 20160926 | EXP | DE-BFARM-16252164 | DE-ALLERGAN-1664627US | ALLERGAN | 81.00 | YR | M | Y | 0.00000 | 20160926 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126202032 | 12620203 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Intramuscular | 100 UNITS, SINGLE | D | C4132 | 103000 | POWDER FOR INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126202032 | 12620203 | 1 | Oesophageal achalasia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126202032 | 12620203 | HO |
| 126202032 | 12620203 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126202032 | 12620203 | Mediastinitis | |
| 126202032 | 12620203 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126202032 | 12620203 | 1 | 20160719 | 20160719 | 0 |